Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease

BMC Neuroscience

Volumn 7, Issue , 2006, Pages

  Van Raamsdonk, Jeremy M ^a   Pearson, Jacqueline ^a   Murphy, Zoe ^a   Hayden, Michael R ^a   Leavitt, Blair R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; MUTANT PROTEIN; PHOSPHOPROTEIN DARPP 32;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN SIZE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE OVEREXPRESSION; HUNTINGTON CHOREA; MALE; MOTOR COORDINATION; MOUSE; MOUSE STRAIN; NONHUMAN; OPEN FIELD TEST; ROTAROD TEST; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ATROPHY; CELL COUNT; CELL SIZE; DISEASE MODELS, ANIMAL; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; HUNTINGTON DISEASE; MICE; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; MOTOR SKILLS; NEOSTRIATUM; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; ROTAROD PERFORMANCE TEST;

EID: 33846576161     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-7-80     Document Type: Article

References (42)

1. Hodgson JG Agopyan N Gutekunst CA Leavitt BR LePiane F Singaraja R A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration Neuron 1999 23 181-192 10.1016/S0896-6273(00)80764-3 10402204
2. Reddy PH Williams M Charles V Garrett L Pike-Buchanan L Whetsell WO Jr Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA Nat Genet 1998 20 198-202 10.1038/2510 9771716
3. Slow EJ van Raamsdonk J Rogers D Coleman SH Graham RK Deng Y Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease Hum Mol Genet 2003 12 1555-1567 10.1093/hmg/ddg169 12812983
4. Cattaneo E Rigamonti D Goffredo D Zuccato C Squitieri F Sipione S Loss of normal huntingtin function: New developments in Huntington's disease research Trends Neurosci 2001 24 182-188 10.1016/S0166-2236(00)01721-5 11182459
5. Van Raamsdonk JM Pearson J Rogers DA Bissada N Vogl AW Hayden MR Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease Hum Mol Genet 2005 14 1379-1392 10.1093/hmg/ddi147 15829505
6. Duyao MP Auerbach AB Ryan A Persichetti F Barnes GT McNeil SM Inactivation of the mouse Huntington's disease gene homolog Hdh Science 1995 269 407-410 10.1126/science.7618107 7618107
7. Nasir J Floresco SB O'Kusky JR Diewert VM Richman JM Zeisler J Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes Cell 1995 81 811-823 10.1016/0092-8674(95)90542-1 7774020
8. Zeitlin S Liu JP Chapman DL Papaioannou VE Efstratiadis A Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue Nat Genet 1995 11 155-163 10.1038/ ng1095-155 7550343
9. O'Kusky JR Nasir J Cicchetti F Parent A Hayden MR Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene Brain Res 1999 818 468-479 10.1016/S0006-8993(98)01312-2 10082833
10. White JK Auerbach W Duyao MP Vonsattel JP Gusella JF Joyner AL Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion Nat Genet 1997 17 404-410 10.1038/ ng1297-404 9398841
11. Dragatsis I Levine MS Zeitlin S Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice Nat Genet 2000 26 300-306 10.1038/81593 11062468
12. Rigamonti D Bauer JH De Fraja C Conti L Sipione S Sciorati C Wild-type huntingtin protects from apoptosis upstream of caspase-3 J Neurosci 2000 20 3705-3713 10804212
13. Ho LW Brown R Maxwell M Wyttenbach A Rubinsztein DC Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease J Med Genet 2001 38 450-452 10.1136/ jmg.38.7.450 11432963
14. Leavitt BR Guttman JA Hodgson JG Kimel GH Singaraja R Vogl AW Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo Am J Hum Genet 2001 68 313-324 1235265 11133364 10.1086/318207
15. Hackam AS Yassa AS Singaraja R Metzler M Gutekunst CA Gan L Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain J Biol Chem 2000 275 41299-41308 10.1074/ jbc.M008408200 11007801
16. Gauthier LR Charrin BC Borrell-Pages M Dompierre JP Rangone H Cordelieres FP Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules Cell 2004 118 127-138 10.1016/j.cell.2004.06.018 15242649
17. Zuccato C Ciammola A Rigamonti D Leavitt BR Goffredo D Conti L Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease Science 2001 293 493-498 10.1126/science.1059581 11408619
18. Zuccato C Tartari M Crotti A Goffredo D Valenza M Conti L Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes Nat Genet 2003 35 76-83 10.1038/ng1219 12881722
19. Hansson O Petersen A Leist M Nicotera P Castilho RF Brundin P Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity Proc Natl Acad Sci USA 1999 96 8727-8732 17584 10411943 10.1073/pnas.96.15.8727
20. Bezprozvanny I Hayden MR Deranged neuronal calcium signaling and Huntington disease Biochem Biophys Res Commun 2004 322 1310-1317 10.1016/ j.bbrc.2004.08.035 15336977
21. Tabrizi SJ Cleeter MW Xuereb J Taanman JW Cooper JM Schapira AH Biochemical abnormalities and excitotoxicity in Huntington's disease brain Ann Neurol 1999 45 25-32 10.1002/ 1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E 9894873
22. Hodgson JG Smith DJ McCutcheon K Koide HB Nishiyama K Dinulos MB Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype Hum Mol Genet 1996 5 1875-1885 10.1093/hmg/5.12.1875 8968738
23. Leavitt BR van Raamsdonk JM Shehadeh J Fernandes HB Murphy Z Graham RK Raymond LA Hayden MR Wild-type huntingtin protects neurons from excitotoxicity J Neurochem 2006 96 4 1121-9 16417581 10.1111/ j.1471-4159.2005.03605.x
24. Li SH Li XJ Huntingtin-protein interactions and the pathogenesis of Huntington's disease Trends Genet 2004 20 146-154 10.1016/ j.tig.2004.01.008 15036808
25. Van Raamsdonk JM Pearson J Slow EJ Hossain SM Leavitt BR Hayden MR Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease J Neurosci 2005 25 4169-4180 10.1523/JNEUROSCI.0590-05.2005 15843620
26. Van Raamsdonk JM Gibson WT Pearson J Murphy Z Lu G Leavitt BR Body weight is modulated by levels of full-length Huntingtin Hum Mol Genet 2006 15 1513-1523 10.1093/hmg/ddl072 16571604
27. Kalchman MA Graham RK Xia G Koide HB Hodgson JG Graham KC Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme J Biol Chem 1996 271 19385-19394 10.1074/jbc.271.32.19385 8702625
28. Van Raamsdonk JM Pearson J Rogers DA Lu G Barakauskas VE Barr AM Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease Exp Neurol 2005 196 266-272 10.1016/j.expneurol.2005.07.021 16129433
29. Ferrante RJ Kubilus JK Lee J Ryu H Beesen A Zucker B Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice J Neurosci 2003 23 9418-9427 14561870
30. Ferrante RJ Ryu H Kubilus JK D'Mello S Sugars KL Lee J Chemotherapy for the brain: The antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease J Neurosci 2004 24 10335-10342 10.1523/JNEUROSCI.2599-04.2004 15548647
31. Gardian G Browne SE Choi DK Klivenyi P Gregorio J Kubilus JK Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease J Biol Chem 2005 280 556-563 15494404
32. Durr A Hahn-Barma V Brice A Pecheux C Dode C Feingold J Homozygosity in Huntington's disease J Med Genet 1999 36 172-173 10051023
33. Kremer B Goldberg P Andrew SE Theilmann J Telenius H Zeisler J A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats N Engl J Med 1994 330 1401-1406 10.1056/NEJM199405193302001 8159192
34. Laccone F Engel U Holinski-Feder E Weigell-Weber M Marczinek K Nolte D DNA analysis of Huntington's disease: Five years of experience in Germany, Austria, and Switzerland Neurology 1999 53 801-806 10489044
35. Myers RH Leavitt J Farrer LA Jagadeesh J McFarlane H Mastromauro CA Homozygote for Huntington disease Am J Hum Genet 1989 45 615-618 1683503 2535231
36. Squitieri F Gellera C Cannella M Mariotti C Cislaghi G Rubinsztein DC Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course Brain 2003 126 946-955 10.1093/brain/awg077 12615650
37. Wexler NS Young AB Tanzi RE Travers H Starosta-Rubinstein S Penney JB Homozygotes for Huntington's disease Nature 1987 326 194-197 10.1038/ 326194a0 2881213
38. Lin CH Tallaksen-Greene S Chien WM Cearley JA Jackson WS Crouse AB Neurological abnormalities in a knock-in mouse model of Huntington's disease Hum Mol Genet 2001 10 137-144 10.1093/hmg/10.2.137 11152661
39. Wheeler VC White JK Gutekunst CA Vrbanac V Weaver M Li XJ Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice Hum Mol Genet 2000 9 503-513 10.1093/hmg/9.4.503 10699173
40. Graham RK Slow EJ Deng Y Bissada N Lu G Pearson J Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models Neurobiol Dis 2006 21 444-455 10.1016/ j.nbd.2005.08.007 16230019
41. Auerbach W Hurlbert MS Hilditch-Maguire P Wadghiri YZ Wheeler VC Cohen SI The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin Hum Mol Genet 2001 10 2515-2523 10.1093/hmg/10.22.2515 11709539
42. Zhang Y Leavitt BR van Raamsdonk JM Dragatsis I Goldowitz D Macdonald ME Hayden MR Friedlander RM Huntingtin inhibits caspase-3 activation EMBO J 2006 [Epub ahead of print]